ENDEXX Corp. (OTCMKTS:EDXC) reported record sales growth for Q2 of fiscal 2017. For the quarter closed March 31, 2017, the firm generated $126,000 in sales, representing a sequential quarterly increase of 47% and a YoY revenue growth of 176%.
Endexx commenced mass manufacturing of Third Eye Chai with The Mad Hatter Coffee & Tea Company. It introduced its new site Phytobites.com to offer an easy and quick access to boost additional sales channel for Phyto-Bites. The company completed on its acquisition of Phyto-Labs LLC to integrate its businesses and further advance proprietary formulas for flavored cannabinoid beverages.
Todd Davis, the CEO, was showcased on Fox News Phoenix live to talk on Phyto-Bites®. He mentioned that they have obtained a lot of promising reception for Phyto-Bites® and have established an infrastructure to boost the growth which they project to increase substantially in the imminent quarters.
They are a pioneer in consumable offering lines derived from industrial hemp, which is naturally rich in phytocannabinoids and organic, and are also thrilled by Cannabinoid-infused gourmet tea named ‘Third Eye CBD Chai’, launched with company’s associate The Mad Hatter Coffee and Tea Co. The first manufacturing run has closed and has officially introduced into delivery and sales.
Lastly, they anticipate a lot of thrilling product launches from their Phyto-Labs acquisition. They have noted that with each new release, they have noted dramatic sales increases, as their clients are confident in their products.
Endexx was recently showcased in an NBC News special report. The report showcased company’s approach to the education and science aspect of bringing CBD and other Phyto-nutrients to the industry. The story has recorded considerable interest in the firm.
The firm is preparing 2 product releases from Phyto-Labs in this month, as it has the ability to strategically enhance advancement of its proprietary formulas for nutritional cannabinoids drinks, topical delivery systems, additional livestock and pet products, and physician-pharmacist formulated capsules.